Olympus expands in cancer tech with $270M buy of BioProtect

Leave a Comment / By /

BioProtect’s balloon spacer device separates the prostate from other structures during cancer radiation.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top